158
Views
1
CrossRef citations to date
0
Altmetric
Endocrinology

Risk Factors for Diabetic Retinopathy in Chinese Patients with Different Diabetes Duration: Association of C-Peptide and BUN/Cr Ratio with Type 2 Diabetic Retinopathy

, , , , &
Pages 4027-4037 | Received 22 May 2023, Accepted 22 Aug 2023, Published online: 06 Sep 2023

References

  • Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–564. doi:10.2337/dc11-1909
  • Liu Y, Yang J, Tao L, et al. Risk factors of diabetic retinopathy and sight-threatening diabetic retinopathy: a cross-sectional study of 13 473 patients with type 2 diabetes mellitus in mainland China. BMJ open. 2017;7(9):e016280. doi:10.1136/bmjopen-2017-016280
  • Zhang X, Saaddine JB, Chou C-F, et al. Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA. 2010;304(6):649–656. doi:10.1001/jama.2010.1111
  • Wang Y, Lin Z, Zhai G, et al. Prevalence of and risk factors for diabetic retinopathy and diabetic macular edema in patients with early-and late-onset diabetes mellitus. Ophthalmic Res. 2022;65(3):293–299. doi:10.1159/000508335
  • Ting DSW, Cheung GCM, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Experiment Ophthalmol. 2016;44(4):260–277. doi:10.1111/ceo.12696
  • Kuo JZ, Wong TY, Rotter JI. Challenges in elucidating the genetics of diabetic retinopathy. JAMA Ophthalmol. 2014;132(1):96–107. doi:10.1001/jamaophthalmol.2013.5024
  • Zhang G, Chen H, Chen W, et al. Prevalence and risk factors for diabetic retinopathy in China: a multi-hospital-based cross-sectional study. Br J Ophthalmol. 2017;101(12):1591–1595. doi:10.1136/bjophthalmol-2017-310316
  • Chen C, Sun Z, Xu W, et al. Associations between alcohol intake and diabetic retinopathy risk: a systematic review and meta-analysis. BMC Endocr Disord. 2020;20(1):1–10. doi:10.1186/s12902-020-00588-3
  • Fotouhi F, Rezvan F, Hashemi H, et al. High prevalence of diabetes in elderly of Iran: an urgent public health issue. J Diabetes Metab Disord. 2022;21(1):777–784. doi:10.1007/s40200-022-01051-x
  • Hammes H-P, Feng Y, Pfister F, et al. Diabetic retinopathy: targeting vasoregression. Diabetes. 2011;60(1):9. doi:10.2337/db10-0454
  • Pang C, Jia L, Jiang S, et al. Determination of diabetic retinopathy prevalence and associated risk factors in Chinese diabetic and pre‐diabetic subjects: shanghai diabetic complications study. Diabetes Metab Res Rev. 2012;28(3):276–283. doi:10.1002/dmrr.1307
  • Wang FH, Liang YB, Peng XY, et al. Risk factors for diabetic retinopathy in a rural Chinese population with type 2 diabetes: the Handan eye study. Acta Ophthalmol. 2011;89(4):e336–e343. doi:10.1111/j.1755-3768.2010.02062.x
  • Xu J, Wei WB, Yuan MX, et al. Prevalence and risk factors for diabetic retinopathy: the Beijing Communities Diabetes Study 6. Retina. 2012;32(2):322–329. doi:10.1097/IAE.0b013e31821c4252
  • Foussard N, Saulnier P-J, Potier L, et al. Relationship between diabetic retinopathy stages and risk of major lower-extremity arterial disease in patients with type 2 diabetes. Diabetes Care. 2020;43(11):2751–2759. doi:10.2337/dc20-1085
  • Wykoff CC, Khurana RN, Nguyen QD, et al. Risk of blindness among patients with diabetes and newly diagnosed diabetic retinopathy. Diabetes Care. 2021;44(3):748–756. doi:10.2337/dc20-0413
  • Rathsman B, Haas J, Persson M, et al. LDL cholesterol level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes mellitus: a nationwide cohort study. J Intern Med. 2021;289(6):873–886. doi:10.1111/joim.13212
  • Bek T. Incidence and risk for developing proliferative diabetic retinopathy after photocoagulation for diabetic maculopathy. Curr Eye Res. 2020;45(8):986–991. doi:10.1080/02713683.2020.1712729
  • Cao K, Wang B, Friedman DS, et al. Diabetic retinopathy, visual impairment, and the risk of six-year death: a cohort study of a rural population in China. Ophthalmic Res. 2021;64(6):983–990. doi:10.1159/000512667
  • Park Y-H, Shin JA, Han J-H, et al. The association between chronic kidney disease and diabetic retinopathy: the Korea national health and nutrition examination survey 2008–2010. PLoS One. 2015;10(4):e0125338. doi:10.1371/journal.pone.0125338
  • Jiang W, Wang J, Shen X, et al. Establishment and validation of a risk prediction model for early diabetic kidney disease based on a systematic review and meta-analysis of 20 cohorts. Diabetes Care. 2020;43(4):925–933. doi:10.2337/dc19-1897
  • Vujosevic S, Aldington SJ, Silva P, et al. Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes Endocrinol. 2020;8(4):337–347. doi:10.1016/S2213-8587(19)30411-5
  • Craig CL, Marshall AL, Sj??str??m M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–1395. doi:10.1249/01.MSS.0000078924.61453.FB
  • Flaxel CJ, Adelman RA, Bailey ST, et al. Diabetic retinopathy preferred practice pattern®. Ophthalmology. 2020;127(1):P66–p145. doi:10.1016/j.ophtha.2019.09.025
  • Trott M, Driscoll R, Pardhan S. Associations between diabetic retinopathy and modifiable risk factors: an umbrella review of meta-analyses. Diabet Med. 2022;39(6):e14796. doi:10.1111/dme.14796
  • Rajalakshmi R, UmaSankari G, Sivaprasad S, et al. Prevalence and risk factors for diabetic retinopathy in prediabetes in Asian Indians. J Diabetes Complications. 2022;36(3):108131. doi:10.1016/j.jdiacomp.2022.108131
  • Zhang Y, Pan GP, Cai JW, Niu YM, Xie LC. Association between transcription factor 7-like 2 C/T polymorphism and diabetic retinopathy risk: a meta-analysis. Ophthalmic Res. 2022;66:66–74.
  • Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50. doi:10.1016/j.diabres.2017.03.024
  • Gangwani RA, Lian JX, McGhee SM, et al. Diabetic retinopathy screening: global and local perspective. Hong Kong Med J. 2016. doi:10.12809/hkmj164844
  • Grunwald JE, Ying G-S, Maguire M, et al. Association between retinopathy and cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC] Study). Am J Cardiol. 2012;110(2):246–253. doi:10.1016/j.amjcard.2012.03.014
  • Son J-W, Jang E-H, Kim M-K, et al. Diabetic retinopathy is associated with subclinical atherosclerosis in newly diagnosed type 2 diabetes mellitus. Diabetes Res Clin Pract. 2011;91(2):253–259. doi:10.1016/j.diabres.2010.11.005
  • Cunha-Vaz J, Ribeiro L, Lobo C. Phenotypes and biomarkers of diabetic retinopathy. Prog Retin Eye Res. 2014;41:90–111. doi:10.1016/j.preteyeres.2014.03.003
  • Chen D, Sun X, Zhao X, et al. Associations of serum uric acid and urinary albumin with the severity of diabetic retinopathy in individuals with type 2 diabetes. BMC Ophthalmol. 2020;20(1):1–5. doi:10.1186/s12886-020-01713-5
  • Qian J, Haq Z, Yang D, et al. Male sex increases the risk of diabetic retinopathy in an urban safety-net hospital population without impacting the relationship between axial length and retinopathy. Sci Rep. 2022;12(1):9780. doi:10.1038/s41598-022-13593-4
  • Hua R, Qu L, Ma B, et al. Diabetic optic neuropathy and its risk factors in Chinese patients with diabetic retinopathy. Invest Ophthalmol Vis Sci. 2019;60(10):3514–3519. doi:10.1167/iovs.19-26825
  • Liu L, Quang ND, Banu R, et al. Hypertension, blood pressure control and diabetic retinopathy in a large population-based study. PLoS One. 2020;15(3):e0229665. doi:10.1371/journal.pone.0229665
  • Bhatt MP, Lim YC, Ha KS. C-peptide replacement therapy as an emerging strategy for preventing diabetic vasculopathy. Cardiovasc Res. 2014;104(2):234–244. doi:10.1093/cvr/cvu211
  • Zhang P, Huang X-B, Xu Y, et al. Prevalence and risk factors of diabetic retinopathy in patients with type 2 diabetes in Shanghai. Int J Ophthalmol. 2021;14(7):1066–1072. doi:10.18240/ijo.2021.07.16
  • Wang J, Xin X, Luo W, et al. Anemia and diabetic kidney disease had joint effect on diabetic retinopathy among patients with type 2 diabetes. Invest Ophthalmol Vis Sci. 2020;61(14):25. doi:10.1167/iovs.61.14.25
  • Hung CC, Lin HY-H, Hwang D-Y, et al. Diabetic retinopathy and clinical parameters favoring the presence of diabetic nephropathy could predict renal outcome in patients with diabetic kidney disease. Sci Rep. 2017;7(1):1236. doi:10.1038/s41598-017-01204-6
  • Hwang H, Kim JY, Oh TK, et al. Relationship between clinical features of diabetic retinopathy and systemic factors in patients with newly diagnosed type II diabetes mellitus. J Korean Med Sci. 2020;35(23):e179. doi:10.3346/jkms.2020.35.e179
  • Borrelli E, Palmieri M, Viggiano P, et al. Photoreceptor damage in diabetic choroidopathy. Retina. 2020;40(6):1062–1069. doi:10.1097/IAE.0000000000002538
  • Huang JX, Liao YF, Li YM. Clinical features and microvascular complications risk factors of early-onset type 2 diabetes mellitus. Curr Med Sci. 2019;39(5):754–758. doi:10.1007/s11596-019-2102-7
  • Çolak S, Kazanci B, Ozçelik Soba D, et al. Effects of diabetes duration and HgA1C level on corneal endothelial morphology. Eur J Ophthalmol. 2021;31(3):967–975. doi:10.1177/1120672120914812
  • Crabtree GS, Chang JS. Management of complications and vision loss from proliferative diabetic retinopathy. Curr Diab Rep. 2021;21(9):33. doi:10.1007/s11892-021-01396-2